JSLLNSEJeena Sikho Lifecare LimitedMediumNeutral
Announced Sat, 30 May · 18:39 IST

Jeena Sikho Lifecare Limited has informed the Exchange regarding Re-appointment of M/s Forvis Mazars LLP as an Internal Auditor of the Company for Financial Year 2026-27.

Management Changes View source PDF

JSLL · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-5.4%1-day move
₹624.00
prior close
₹570.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-6.1-5.6-6.3-13.7-5.4+12.2+4.6+0.8-1.4-6.4-1.5-6.1
Up moveDown movePending
AI summary

Jeena Sikho Lifecare Limited reported strong audited financial results for FY 2025-26 ending March 31, 2026. Standalone revenue from operations grew 71% to Rs. 80,134.64 lakhs from Rs. 46,907.19 lakhs in the previous year. Profit before tax more than doubled to Rs. 29,787.47 lakhs from Rs. 10,757.76 lakhs, while net profit for the year stood at Rs. 22,217.57 lakhs (up from Rs. 7,994.33 lakhs). The Board recommended a final dividend of Rs. 4.50 per equity share (face value Rs. 2 each), subject to shareholder approval. Walker Chandiok & Co LLP issued an unmodified (clean) audit opinion on both standalone and consolidated financial results. The company also re-appointed M/s Forvis Mazars LLP as Internal Auditor for FY 2026-27 based on the Audit Committee's recommendation.

Likely market impact

The company delivered exceptional year-on-year growth with revenue and profit more than doubling. The clean audit opinion and dividend recommendation signal financial health, which could be positive for shareholder sentiment. The stock trades on NSE (JSLL) and BSE (544476).